| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84466 |
p-NO2-Bn-DOTA S-2-(4-硝基苄基)-1,4,7,10-四氮杂环十二烷四乙酸 |
169 |
h |
2024-12-19 |
| 84467 |
Ethyl (S)-1-((1-((4-((((4-nitrophenoxy)carbonyl) oxy)methyl)phenyl)amino)-1-oxo-5-ureidopenta n-2-yl)carbamoyl)cyclobutane-1-carboxylate,ADC定制 |
144 |
wyh |
2024-12-19 |
| 84468 |
Py-ds-Prp-Osu,ADC试剂 |
285 |
kx |
2024-12-19 |
| 84469 |
Mal-amido-PEG10-C2-NHS ester CAS:1137109-22-8 |
190 |
zyl |
2024-12-19 |
| 84470 |
Mal-PEG4-Val-Ala-PAB-PNP,马来酰亚胺-四聚乙二醇-缬氨酸-丙氨酸-对氨基苯甲酸-PNP酯 |
205 |
WYQ |
2024-12-19 |
| 84471 |
DOTA-NAPamide DOTA-纳帕胺 |
222 |
h |
2024-12-19 |
| 84472 |
Mal-PEG2-Val-Ala-PAB-PNP,马来酰亚胺-二聚乙二醇-缬氨酸-丙氨酸-对氨基苯甲酸-PNP酯 |
150 |
WYQ |
2024-12-19 |
| 84473 |
Bocaminooxyacetamide-PEG2-Azido |
149 |
zyl |
2024-12-19 |
| 84474 |
cas:2748039-77-0,Alkyne-Val-Cit-PAB-PNP,ADC定制 |
236 |
wyh |
2024-12-19 |
| 84475 |
SPDP-Val-Cit-PAB-OH,C26H36N6O5S2 |
146 |
WYQ |
2024-12-19 |
| 84476 |
cas:1116086-09-9,Fmoc-Phe -Lys(Trt)-PAB-PNP, ADC试剂 |
136 |
kx |
2024-12-19 |
| 84477 |
N3-C5-NHS ester CAS:866363-70-4 |
172 |
zyl |
2024-12-19 |
| 84478 |
CAS号:2055024-54-7,化合物:Boc-PEG4-Val-Cit-PAB-OH,叔丁酯-四聚乙二醇-VAL-CIT-PAB-羟基 |
149 |
WYQ |
2024-12-19 |
| 84479 |
DOTA-DPhe1-Tyr3-octreotide DOTA-DPhe 1-Tyr 3-奥曲肽 |
167 |
h |
2024-12-19 |
| 84480 |
CAS号:870487-10-8,化合物:Boc-Val-Cit-PAB-PNP |
139 |
WYQ |
2024-12-19 |
| 84481 |
DOTA-PESIN 金属螯合剂DOTA偶联多肽 |
176 |
h |
2024-12-19 |
| 84482 |
(Ac)Phe-Lys(Alloc)-PABC-PNP, ADC试剂 |
271 |
kx |
2024-12-19 |
| 84483 |
Mal-PEG8-Val-Cit-PAB-PNP,C47H67N9O19 |
218 |
WYQ |
2024-12-19 |
| 84484 |
DBCO-PEG3-Val-Cit-PAB-PNP,ADC定制 |
155 |
wyh |
2024-12-19 |
| 84485 |
[d-Phe7]-α-MSH3-10 |
193 |
h |
2024-12-19 |
| 84486 |
cas:863971-53-3,Fmoc-Val-Cit-PAB-PNP, ADC试剂 |
161 |
kx |
2024-12-19 |
| 84487 |
CAS: 2055041-37-5, Mal-PEG1-Val-Cit-PAB-OH(有时也被称为Mal-PEG1-Val-Cit-PABC-OH) |
180 |
WYQ |
2024-12-19 |
| 84488 |
Mal-L-PA-NH-Boc CAS:1491152-23-8 |
138 |
zyl |
2024-12-19 |
| 84489 |
cas:2504147-53-7 ,Mal-amido-PEG2-Val-Cit-PAB-OH,ADC定制 |
183 |
wyh |
2024-12-19 |
| 84490 |
Mal-PEG1-Val-Cit-OH,马来酰亚胺-一聚乙二醇-VAL-CIT-羟基 |
179 |
WYQ |
2024-12-19 |
| 84491 |
cas:1342820-51-2,SGD-1910, ADC试剂 |
204 |
kx |
2024-12-19 |
| 84492 |
Ald-Ph-amido-PEG2-C2-Pfp ester CAS:2101206-60-2 |
177 |
zyl |
2024-12-19 |
| 84493 |
cas:1228105-52-9,DM4-SMCC, ADC试剂 |
180 |
kx |
2024-12-19 |
| 84494 |
马来酰亚胺-八聚乙二醇-缬氨酸-瓜氨酸-PAB-PNP酯,ADC定制 |
170 |
wyh |
2024-12-19 |
| 84495 |
cas:863971-56-6,Val-Cit-PAB-MMAF, ADC试剂 |
137 |
kx |
2024-12-19 |
| 84496 |
SPDMB CAS:2101206-29-3合成方法 |
164 |
zyl |
2024-12-19 |
| 84497 |
cas:2055041-39-7,Mal-PEG4-Val-Cit-PAB-OH,ADC定制 |
160 |
wyh |
2024-12-19 |
| 84498 |
cas:1347750-81-5,Mal-NH-PEG2-CH2CH2COOPFP ester, ADC试剂 |
133 |
kx |
2024-12-19 |
| 84499 |
金属螯合剂DOTA偶联α-MSH八肽类似物 |
127 |
h |
2024-12-19 |
| 84500 |
cas:1286715-33-0,2,5-Dioxopyrrolidin-1-yl 4-methyl-4-((2-methyl-5-oxo-5-(2-(trimethylsilyl)ethoxy)pentan-2-yl)disulfanyl)pentanoate |
170 |
kx |
2024-12-19 |
| 84501 |
DOTA-conjugated multivalent cyclic-RGD DOTA-共轭多价环RGD肽树枝状大分子 |
150 |
h |
2024-12-19 |
| 84502 |
Azidoethyl-SS-ethylazide CAS:352305-38-5 |
133 |
zyl |
2024-12-19 |
| 84503 |
CAS: 870487-09-5, Boc-Val-Cit-PAB |
139 |
WYQ |
2024-12-19 |
| 84504 |
cas:2101206-67-9,Ald-Ph-amido-PEG1-C2-Pfp ester, ADC试剂 |
124 |
kx |
2024-12-19 |
| 84505 |
Ald-Ph-amido-PEG11-NH-Boc CAS:1245813-70-0 |
189 |
zyl |
2024-12-19 |
| 84506 |
HSA-2-iminothiolane-DOTA HSA-2-亚氨基硫醇-DOTA |
146 |
h |
2024-12-19 |
| 84507 |
cas:1222787-24-7,2,5-Dioxopyrrolidin-1-yl 4-((2-((2-(2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxy)acetamido)ethyl)amino)ethyl)disulfanyl)-4-oxobutanoate |
259 |
kx |
2024-12-19 |
| 84508 |
Tr-PEG5-OH CAS:141282-24-8物理化学性质 |
178 |
zyl |
2024-12-19 |
| 84509 |
CAS: 870487-08-4,Boc-Val-Cit,(S)-2-((S)-2-((叔丁氧基羰基)氨基)-3-甲基丁酰胺基)-5-脲基戊酸 |
144 |
WYQ |
2024-12-19 |
| 84510 |
DOTA-8-Aoc-BBN[7-14]NH |
174 |
h |
2024-12-19 |